Research and Markets: IntelliNews - Romania Pharmaceutical Report - August 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/gfv8bv/intellinews_roma) has announced the addition of the "IntelliNews - Romania Pharmaceutical Report - August 2012" report to their offering.

“IntelliNews - Romania Pharmaceutical Report - August 2012”

The IntelliNews Romanian Pharmaceutical Report offers an extensive summary of the Romanian pharmaceuticals market, segmented into production and distribution. It includes a complete coverage of the latest developments, trends and corporate news, accompanied by thorough statistics and comments. This sector report is ideal to keep you abreast on recent company and industry news. Written by local professionals, it is a unique market and business intelligence analysis, tailored to save time by providing in-depth information, while helping you to make confident and informed business decisions.

Executive Summary

Sales of pharmaceuticals dropped by 2.5% y/y to EUR 626mn (RON 2.77bn) in Q2/2012, losing ground from the 18% y/y expansion in Q1. In local currency, sales advanced by 4.4% y/y during the quarter, but the growth also eased significantly from the 21.6% y/y surge in Q1. The slowdown in growth pace (in RON) and the moderate decline of the market in volume terms (down by 0.5% y/y in Q2) reveal companies' tendency to shift focus from market share expansion to profitability, after the government's attempt to enforce the claw-back tax.

Projections for performance of the pharma market this year remain largely on the optimistic side, ranging from 5.7% y/y to 8.9% y/y growth in local currency. Nonetheless, the evolution of the market will be largely impacted by regulatory measures such as the controversial clawback tax amended this August and also by the budget allotted for subsidized drugs.

Imports of medicines advanced by 13.9% y/y to EUR 645mn in Q1/2012, according to our calculations based on official statistics. Exports increased by 21.1% y/y during the period, but their value remains however low - EUR 199.1mn, thus maintaining the trade deficit in the sector high. The pharmaceutical market supply remains largely import-oriented, as part of the production from the 22 local plants also goes to exports. Market researches show that the cumulated sales of top 15 local medicine producers accounted for approximately 12% of the market in 2011.

Pharmacy chains continue to expand, yet the growth pace has slowed down visibly, as large chains tend to shift focus on business consolidation and are cautious in approaching new potential opportunities. The total number of pharmacies and pharmaceutical points increased by 4% y/y in 2011, compared to 4.5% y/y in 2010, according to official statistics.

Key Topics Covered:

Executive Summary

Market Overview

Drug Producers

Distribution and Retail

Table 1 Pharma quarterly sales in 2010-2012 (RON mn & EUR mn , y/y in %)

Table 2 Pharma sales - trailing 12 months (2010-2012, RON mn & EUR mn)

Table 3 Sales in past 12 months ending Jun 2012 by therapeutical groups

Table 4 Projections for Romanian pharma market (2012-2016)

Table 5 Foreign Trade vs. Sales 2007-2012 (EUR mn)

Table 6 Top 10 pharma companies in 12 months ending:

Table 7 Major pharmaceutical producers in 2010-2011 (Selective financials, RON mn)